<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04234295</url>
  </required_header>
  <id_info>
    <org_study_id>19-003803</org_study_id>
    <nct_id>NCT04234295</nct_id>
  </id_info>
  <brief_title>Investigating the Effect of Obesity on Eosinophil Recruitment in Human Adipose Tissue</brief_title>
  <official_title>Investigating the Effect of Obesity on Eosinophil Recruitment in Human Adipose Tissue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to better understand the relationship between inflammation in adipose
      tissue (AT) and insulin resistance.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2020</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of eosinophils in adipose tissue</measure>
    <time_frame>baseline</time_frame>
    <description>eosinophil number will be measured by flow cytometry in subcutaneous (superficial) adipose tissue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between eosinophil content and body mass index (BMI)</measure>
    <time_frame>baseline</time_frame>
    <description>Measured as a linear regression between BMI (defined as the weight in Kg/height in square m; kg/m2) and eosinophil number in the fat</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quantification of the difference in gene methylation in eosinophils from lean and obese subjects</measure>
    <time_frame>baseline</time_frame>
    <description>Gene methylation of eosinophils will be quantified in samples derived from lean and obese fat biopsy</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Obese</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Lean, Healthy Controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with a body mass index (BMI) of 25 or less will have a fat tissue biopsy collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese, Non-Diabetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject with a BMI between 30 and 50 kg/m2 will have fat tissue biopsy collected</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fat Tissue Biopsy</intervention_name>
    <description>If subjects are scheduled for a surgical procedure a fat sample will be collected during the beginning of the surgery. If subjects are not scheduled for a surgical procedure, a small sample of subcutaneous (superficial) fat tissue from subjects abdomen area will be collected.</description>
    <arm_group_label>Lean, Healthy Controls</arm_group_label>
    <arm_group_label>Obese, Non-Diabetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults ages 30-50 years

          -  Non-smokers

          -  Lean subjects with a BMI of 25 or less, gender specific normal body fat,

          -  Obese, non-diabetic subjects with a BMI between 30 and 50 and taking no medications
             affecting glucose metabolism or lipid metabolism

          -  subjects scheduled for an elective laparoscopic or laparotomy abdominal surgery

        Exclusion Criteria:

          -  Receiving corticosteroid therapy or have a history of asthma, COPD or atopic syndrome

          -  taking any biologic treatment for any autoimmune disorder

          -  Taking any leukotriene receptor antagonist acting medications (ex. Montelukast)

          -  smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena De Filippis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Branch</last_name>
      <phone>480-301-9392</phone>
      <email>branch.emily@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>January 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>January 29, 2020</last_update_submitted>
  <last_update_submitted_qc>January 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Elena Anna (Eleanna) De Filippis, M.D., Ph.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

